Literature DB >> 30846502

Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature.

Massimo Granai1, Maria Raffaella Ambrosio1, Ayse Akarca2, Lucia Mundo1, Federica Vergoni3, Raffaella Santi3, Virginia Mancini1, Gioia di Stefano3, Teresa Amato1, Cristiana Bellan1, Benedetta Puccini3, Ester Sorrentino1, Kikkeri N Naresh4, Lorenzo Leoncini5, Teresa Marafioti2, Stefano Lazzi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30846502      PMCID： PMC6545845          DOI： 10.3324/haematol.2018.215053

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma.

Authors:  Delin Zhu; Helen McCarthy; Christian H Ottensmeier; Peter Johnson; Terry J Hamblin; Freda K Stevenson
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

Review 2.  Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point.

Authors:  Ebru Linke-Serinsöz; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Semin Diagn Pathol       Date:  2017-04-07       Impact factor: 3.464

3.  Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma.

Authors:  Madhu P Menon; Lloyd Hutchinson; Joanne Garver; Elaine S Jaffe; Bruce A Woda
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

4.  Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.

Authors:  Gregory K Hong; Margaret L Gulley; Wen-Hai Feng; Henri-Jacques Delecluse; Elizabeth Holley-Guthrie; Shannon C Kenney
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Epstein-Barr virus lytic cycle involvement in diffuse large B cell lymphoma.

Authors:  Melina Cohen; Aldana Georgina Vistarop; Fuad Huaman; Marina Narbaitz; Fernanda Metrebian; Elena De Matteo; María Victoria Preciado; Paola Andrea Chabay
Journal:  Hematol Oncol       Date:  2017-07-14       Impact factor: 5.271

6.  A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.

Authors:  Shi-Dong Ma; Subramanya Hegde; Ken H Young; Ruth Sullivan; Deepika Rajesh; Ying Zhou; Ewa Jankowska-Gan; William J Burlingham; Xiaoping Sun; Margaret L Gulley; Weihua Tang; Jenny E Gumperz; Shannon C Kenney
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

7.  Epstein-Barr virus-positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma.

Authors:  E Orlandi; M Paulli; A Viglio; G Pagnucco; R Riboni; F Baldanti; M Lazzarino
Journal:  Br J Haematol       Date:  2001-02       Impact factor: 6.998

Review 8.  Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).

Authors:  J M Kim; D S Chen
Journal:  Ann Oncol       Date:  2016-05-20       Impact factor: 32.976

9.  BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.

Authors:  Xubing Long; Yuqing Li; Mengtian Yang; Lu Huang; Weijie Gong; Ersheng Kuang
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

Review 10.  EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.

Authors:  Stefan D Dojcinov; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Pathogens       Date:  2018-03-07
View more
  4 in total

Review 1.  Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.

Authors:  Siba El Hussein; Kenna R M Shaw; Francisco Vega
Journal:  Mod Pathol       Date:  2020-07-03       Impact factor: 7.842

2.  Epstein-Barr virus reactivation influences clonal evolution in human herpesvirus-8-related lymphoproliferative disorders.

Authors:  Massimo Granai; Mattia Facchetti; Virginia Mancini; Jacqueline Goedhals; Alicia Sherriff; Lucia Mundo; Cristiana Bellan; Teresa Amato; Ester Sorrentino; Marco Ungari; Martine Raphael; Lorenzo Leoncini; Fabio Facchetti; Stefano Lazzi
Journal:  Histopathology       Date:  2021-10-04       Impact factor: 7.778

3.  Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program.

Authors:  Massimo Granai; Lucia Mundo; Ayse U Akarca; Maria Chiara Siciliano; Hasan Rizvi; Virginia Mancini; Noel Onyango; Joshua Nyagol; Nicholas Othieno Abinya; Ibrahim Maha; Sandra Margielewska; Wenbin Wi; Michele Bibas; Pier Paolo Piccaluga; Leticia Quintanilla-Martinez; Falko Fend; Stefano Lazzi; Lorenzo Leoncini; Teresa Marafioti
Journal:  Infect Agent Cancer       Date:  2020-05-06       Impact factor: 2.965

4.  Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression.

Authors:  Massimo Granai; Stefano Lazzi; Virginia Mancini; Ayse Akarca; Raffaella Santi; Federica Vergoni; Ester Sorrentino; Raffaella Guazzo; Lucia Mundo; Gabriele Cevenini; Claudio Tripodo; Gioia Di Stefano; Benedetta Puccini; Maurilio Ponzoni; Elena Sabattini; Claudio Agostinelli; Nuray Bassüllü; Tülay Tecimer; Ahu Senem Demiroz; Leah Mnango; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Teresa Marafioti; Falko Fend; Lorenzo Leoncini
Journal:  Histopathology       Date:  2021-07-05       Impact factor: 7.778
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.